Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Shuttle Pharmaceuticals Holdings Inc (SHPH)

Shuttle Pharmaceuticals Holdings Inc (SHPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,291
  • Shares Outstanding, K 3,665
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,590 K
  • EBIT $ -7 M
  • EBITDA $ -5 M
  • 60-Month Beta -1.32
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.15
  • Most Recent Earnings $-1.59 on 11/13/24
  • Next Earnings Date 11/11/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8338 +5.78%
on 11/19/24
2.2500 -60.80%
on 10/29/24
-0.4080 (-31.63%)
since 10/21/24
3-Month
0.8338 +5.78%
on 11/19/24
3.3000 -73.27%
on 09/05/24
-1.0980 (-55.45%)
since 08/21/24
52-Week
0.8338 +5.78%
on 11/19/24
4.9464 -82.17%
on 01/19/24
-3.1020 (-77.86%)
since 11/21/23

Most Recent Stories

More News
Shuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma Treatment

Shuttle Pharmaceuticals reports progress in its Phase 2 trial of Ropidoxuridine for glioblastoma and financial updates.Quiver AI SummaryShuttle Pharmaceuticals Holdings, Inc. has announced significant...

SHPH : 0.8800 (-2.00%)
Shuttle Pharma Provides Third Quarter 2024 Corporate Update

SHPH : 0.8800 (-2.00%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.8800 (-2.00%)
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News

Shuttle Pharmaceuticals (NASDAQ: SHPH), a rising force in cancer treatment innovation, has experienced a notable boost in its stock price following a recent wave of positive developments. Shares of Shuttle...

SHPH : 0.8800 (-2.00%)
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

SHPH : 0.8800 (-2.00%)
Shuttle Pharma Pays Off Senior Secured Convertible Note

SHPH : 0.8800 (-2.00%)
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma

SHPH : 0.8800 (-2.00%)
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

SHPH : 0.8800 (-2.00%)
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024

SHPH : 0.8800 (-2.00%)
Shuttle Pharma Announces Results of Pre-IND Meeting with FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma

/PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving...

SHPH : 0.8800 (-2.00%)

Business Summary

Shuttle Pharmaceuticals Holdings Inc. is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer patients treated with radiation therapy. Shuttle Pharmaceuticals Holdings Inc. is based in ROCKVILLE, Md.

See More

Key Turning Points

3rd Resistance Point 0.9680
2nd Resistance Point 0.9340
1st Resistance Point 0.9080
Last Price 0.8820
1st Support Level 0.8480
2nd Support Level 0.8140
3rd Support Level 0.7880

See More

52-Week High 4.9464
Fibonacci 61.8% 3.3754
Fibonacci 50% 2.8901
Fibonacci 38.2% 2.4048
Last Price 0.8820
52-Week Low 0.8338

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar